Terminology Service for NFDI4Health
All terms in BAO
| Label | Id | Description |
|---|---|---|
| adenosine A3 receptor agonist | CHEBI_73319 | |
| tyrosinemia | DOID_9275 | [An amino acid metabolic disorder that involves impaired break down of the amino acid tyrosine.] |
| hyperhomocysteinemia | DOID_9279 | [An amino acid metabolic disorder that involves an abnormally large level of homocysteine in the blood.] |
| protein kinase inhibitor | CHEBI_37699 | |
| estrogen receptor agonist | CHEBI_63951 | |
| acrocallosal syndrome | DOID_9250 | [A syndrome that is an autosomal recessive disorder, which is characterized by corpus callosum agenesis, polydactyly, multiple dysmorphic features, motor and mental retardation.] |
| cellulose synthesis inhibitor | CHEBI_63958 | |
| adenosine A1 receptor antagonist | CHEBI_63957 | |
| adenosine receptor antagonist | CHEBI_71232 | |
| Alagille syndrome | DOID_9245 | [A liver disease that is characterized by an accumulation of bile in the liver resulting from a reducted number of liver small bile ducts.] |
| liver disease | DOID_409 | |
| fragrance | CHEBI_48318 | |
| Pallister-Hall syndrome | DOID_9248 | |
| cerebral amyloid angiopathy | DOID_9246 | [An amyloidosis where amyloid protein progressively deposits in cerebral blood vessel walls with subsequent degenerative vascular changes that usually result in spontaneous cerebral hemorrhage, ischemic lesions and progressive dementia.] |
| amyloidosis | DOID_9120 | [An acquired metabolic disease that involves abnormal deposited of amyloid proteins in organs and/or tissues.] |
| EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor | CHEBI_50643 | |
| trypanocidal drug | CHEBI_36335 | |
| GABA-gated chloride channel antagonist | CHEBI_38999 | |
| bone density conservation agent | CHEBI_50646 | |
| scabicide | CHEBI_73333 |